Pharmaceutical formulations of a Brutons tyrosine kinase inhibitor | Patent Number 10213386

US 10213386 B2

Application Number15970721

Publication NumberUS 20180250234 A1

Pendency9 months, 29 days

Filled DateMay 3, 2018

Priority DateMar 3, 2015

Publication DateSep 6, 2018

Expiration DateMar 2, 2035

Inventor/ApplicantsChing W. Chong
Heow Tan
Harisha Atluri
Robert Kuehl

ExaminesHENLEY III, RAYMOND J

Art Unit1629

Technology Center1600

Assignments

Law Firm

You must be logged in to view

Attorneys

Subscription-Only

See the invalidated claims, subscribe to our Concierge Program.

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.